Letter to the Editor
Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
Table 1
Comparison of epidemiological and large intestine histopathology data between untreated CHC
patients and controls.
| | CHC patients n = 24 | Controls n = 10 | P value |
| Gender (male/female) | 14/10 | 6/4 | 1 | Age (years) | | | .098 | BMI (kg/m2) | | | .903 | Inflammation (%) | 14/24 (58.3%) | 6/10 (60%) | 1 | Architectural disorder and
decrease
of mucus production (%) | 6/24 (25%) | 0/10 (0%) | .148 | Paneth cells (%) | 4/24 (16.7%) | 0/10 (0%) | .296 | Lymphoid follicles | | | .440 |
|
|